| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/27/1998 | US5712107 Substitutes for modified starch and latexes in paper manufacture |
| 01/27/1998 | US5712105 Monoclonal antibody to human glicentin, hybridoma for producing said antibody and assay method for human glicentin using said antibody |
| 01/27/1998 | US5712104 Screening test for cancer, aids/hiv, influenza |
| 01/27/1998 | US5712095 Rapid and sensitive detection of antibiotic-resistant mycobacteria using oligonucleotide probes specific for ribosomal RNA precursors |
| 01/27/1998 | US5712094 Methods for detecting modulators of cytokine action |
| 01/27/1998 | US5712092 Papillomavirus probe and process for in vitro diagnosis of papillomavirus infections |
| 01/27/1998 | US5712089 Proteins and infecting bacteria |
| 01/27/1998 | US5711983 Dinoflagellate biomass, methods for its production, and compositions containing the same |
| 01/27/1998 | US5711964 Cellular metabolism and cationic lipids |
| 01/27/1998 | CA2122987C Dye transfer inhibiting compositions |
| 01/26/1998 | CA2203745A1 Pro-protein converting enzyme |
| 01/25/1998 | CA2207071A1 Aprotinin variants having improved properties |
| 01/24/1998 | CA2209577A1 Protein engineering of glucoamylase to increase ph, optimum, substrate specificity and thermostability |
| 01/22/1998 | WO1998002748A1 Methods to detect hk2 polypeptides |
| 01/22/1998 | WO1998002746A1 Peptide reagent for the detection of human cytomegalovirus (cmv) |
| 01/22/1998 | WO1998002583A1 Novel catalytic rna molecules |
| 01/22/1998 | WO1998002582A2 Methods for detecting and amplifying nucleic acid sequences using modified oligonucleotides having increased target specific t¿m? |
| 01/22/1998 | WO1998002580A2 Signal amplification method |
| 01/22/1998 | WO1998002573A1 Denaturation of double-stranded nucleic acid |
| 01/22/1998 | WO1998002567A2 PROCESS FOR THE PREPARATION OF CEPHALOSPORINS USING $i(ACREMONIUM CHRYSOGENUM) |
| 01/22/1998 | WO1998002565A1 TRANSFORMATION OF $i(PICHIA METHANOLICA) |
| 01/22/1998 | WO1998002564A1 Hybrid herpes virus/epstein-barr virus vector |
| 01/22/1998 | WO1998002563A1 Transgenes with floury2 gene signal peptide and transgenic plants containing the transgenes |
| 01/22/1998 | WO1998002562A2 Chimera gene with several herbicide resistant genes, plant cell and plant resistant to several herbicides |
| 01/22/1998 | WO1998002561A1 Method of producing particles containing nucleic acid sequences in yeast |
| 01/22/1998 | WO1998002560A2 Genomic sequence of rhizobium sp. ngr 234 symbiotic plasmid |
| 01/22/1998 | WO1998002559A1 Over-expression of proteins |
| 01/22/1998 | WO1998002557A2 MAMMALIAN TNF-α CONVERTASES |
| 01/22/1998 | WO1998002556A2 Screening for and use of an esterase for a stereospecific resolution |
| 01/22/1998 | WO1998002555A1 Applications for regulatory region of nos isoforms |
| 01/22/1998 | WO1998002554A2 Cytochrome p450 expression in enterobacteria |
| 01/22/1998 | WO1998002553A1 Recombinant kynurenine-3-hydroxylase enzyme and process for its preparation |
| 01/22/1998 | WO1998002552A2 Vaccine compositions |
| 01/22/1998 | WO1998002549A1 Recombinant dna-vector comprising genomic equine arteritis virus sequences |
| 01/22/1998 | WO1998002548A2 Infectious papillomavirus pseudoviral particles |
| 01/22/1998 | WO1998002547A2 Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications |
| 01/22/1998 | WO1998002546A2 Dna immunization against chlamydia infection |
| 01/22/1998 | WO1998002545A2 Compositions and methods for plant pathogen resistance |
| 01/22/1998 | WO1998002544A1 Human interleukin 12 gene expression regulating sequences |
| 01/22/1998 | WO1998002543A1 Novel vegf-like factors |
| 01/22/1998 | WO1998002542A1 Cytokine receptor signal transduction chain |
| 01/22/1998 | WO1998002541A1 Gamma-heregulin |
| 01/22/1998 | WO1998002540A1 Chimeric heteromultimer adhesins |
| 01/22/1998 | WO1998002539A1 GENES FROM 20q13 AMPLICON AND THEIR USES |
| 01/22/1998 | WO1998002538A1 Melanoma associated peptide analogues and vaccines against melanoma |
| 01/22/1998 | WO1998002537A1 Site-specific mutagenesis and mutant selection utilizing antibiotic-resistant markers encoding gene products having altered substrate specificity |
| 01/22/1998 | WO1998002536A2 Preparation of pichia methanolica auxotrophic mutants |
| 01/22/1998 | WO1998002535A1 Method for effecting site-directed mutagenesis |
| 01/22/1998 | WO1998002534A2 Transgenic animal whose expression of the opiate receptors is modified |
| 01/22/1998 | WO1998002530A1 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 01/22/1998 | WO1998002529A1 Highly productive packaging lines |
| 01/22/1998 | WO1998002527A1 Imidazolinone herbicide resistant sugar beet plants |
| 01/22/1998 | WO1998002526A1 Imidazolinone herbicide resistant sugar beet plants |
| 01/22/1998 | WO1998002525A1 Pituitary differentiation factor and methods of use thereof |
| 01/22/1998 | WO1998002523A1 Vaccine preparations |
| 01/22/1998 | WO1998002463A1 THERAPEUTIC MULTISPECIFIC COMPOUNDS COMPRISED OF ANTI-FCα RECEPTOR ANTIBODIES |
| 01/22/1998 | WO1998002462A1 Immunoglobulin superfamily domains and fragments with increased solubility |
| 01/22/1998 | WO1998002459A1 Human monocyte chemotactic proprotein |
| 01/22/1998 | WO1998002458A1 Differentiation inhibitor |
| 01/22/1998 | WO1998002457A1 Subunit respiratory syncytial virus vaccine preparation |
| 01/22/1998 | WO1998002456A2 Human c-type lectin |
| 01/22/1998 | WO1998002455A2 Transcriptional intermediary factor-2 (tfif2) |
| 01/22/1998 | WO1998002454A2 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 01/22/1998 | WO1998002449A1 Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon |
| 01/22/1998 | WO1998002399A1 Method and device for purifying and enriching molecules |
| 01/22/1998 | WO1998002191A2 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules |
| 01/22/1998 | WO1998002190A2 Cationic amphiphile/dna complexes |
| 01/22/1998 | WO1998002178A1 Methods of controlling axonal growth |
| 01/22/1998 | WO1998002170A1 Method of inducing vasodilation and treating pulmonary hypertension using adenoviral-mediated transfer of the nitric oxide synthase gene |
| 01/22/1998 | WO1998002144A1 Compositions containing at least one nucleic acid |
| 01/22/1998 | WO1998002039A1 Bacillus thuringiensis strains showing improved production of certain lepidopteran-toxic crystal proteins |
| 01/22/1998 | WO1998002036A2 Animal model knock-out for a neuronal intermediate filament protein |
| 01/22/1998 | WO1997038083A3 New member of the multiple-tumor aberrant growth gene family |
| 01/22/1998 | DE19702835A1 New nucleic acid encoding protein that increases neuronal cell proliferation |
| 01/22/1998 | DE19629271A1 Isolating DNA from microorganisms that can not be cultured |
| 01/22/1998 | DE19628894A1 Verfahren zum Nachweis für Effektoren intra- und/oder interzellulärer Protein-Protein-Wechselwirkungen A method for detecting effectors for intra- and / or inter-cellular protein-protein interactions |
| 01/22/1998 | CA2295500A1 Methods of controlling axonal growth |
| 01/22/1998 | CA2267620A1 Immunoglobulin superfamily domains and fragments with increased solubility |
| 01/22/1998 | CA2262814A1 Highly productive packaging lines_ |
| 01/22/1998 | CA2261023A1 Novel catalytic rna molecules |
| 01/22/1998 | CA2261019A1 Methods to detect hk2 polypeptides |
| 01/22/1998 | CA2260771A1 Method of inducing vasodilation and treating pulmonary hypertension using adenoviral-mediated transfer of the nitric oxide synthase gene |
| 01/22/1998 | CA2260749A1 Methods for detecting rna analytes using modified probes |
| 01/22/1998 | CA2260738A1 Human monocyte chemotactic proprotein |
| 01/22/1998 | CA2260288A1 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 01/22/1998 | CA2260284A1 Compositions containing at least one nucleic acid |
| 01/22/1998 | CA2260132A1 Method and device for purifying and enriching molecules |
| 01/22/1998 | CA2260079A1 Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications |
| 01/22/1998 | CA2260034A1 Cationic amphiphile/dna complexes |
| 01/22/1998 | CA2260029A1 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules |
| 01/22/1998 | CA2259964A1 Recombinant dna-vector comprising genomic equine arteritis virus sequences |
| 01/22/1998 | CA2259918A1 Signal amplification method |
| 01/22/1998 | CA2259371A1 Therapeutic multispecific compounds comprised of anti-fc.alpha. receptor antibodies |
| 01/22/1998 | CA2259136A1 Pituitary differentiation factor and methods of use thereof |
| 01/22/1998 | CA2258721A1 Chimeric heteromultimer adhesins |
| 01/22/1998 | CA2257823A1 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 01/22/1998 | CA2257822A1 Infectious papillomavirus pseudoviral particles |
| 01/22/1998 | CA2257383A1 Recombinant kynurenine-3-hydroxylase enzyme and process for its preparation |
| 01/22/1998 | CA2255683A1 Over-expression of proteins |
| 01/22/1998 | CA2210445A1 Baking method and associated apparatus |